Table 4.
Factors Associated With Survival in Multivariate Analysis
| Factor | HR (95%CI) | p Value |
|---|---|---|
| Age: ≤60/>60 | 0.835 (0.486–1.436) | 0.515 |
| Gender: male/female | 1.208 (0.701–2.084) | 0.496 |
| ECOG: ≥2/0–1 | 0.477 (0.271–0.838) | 0.010 |
| Primary state: has been removed/not to remove | 1.110 (0.499–2.470) | 0.799 |
| Number of transferred organs: 1/>1 | 0.748 (0.432–1.294) | 0.300 |
| Pleural effusion: yes/no | 0.549 (0.169–1.783) | 0.318 |
| Peritoneal effusion: yes/no | 0.731 (0.379–1.410) | 0.350 |
| Previous chemotherapy lines: 2/≥3 | 0.609 (0.350–1.060) | 0.079 |
| Prior targeted treatments: yes/no | 0.708 (0.410–1.223) | 0.215 |
| Prior immunotherapy: yes/no | 1.074 (0.481–2.396) | 0.861 |
| Single or combined therapy | 1.360 (0.487–3.800) | 0.557 |
| Time from diagnosis of metastatic disease: ≤18 months/>18 months | 1.779 (0.930–3.404) | 0.082 |
CI, confidence interval; ECOG, Eastern Cooperative Oncology Group; HR, hazard ratio.